- Home
- TRC vs ZBIO Comparison
TRC vs ZBIO Comparison
Compare TRC & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRC
- ZBIO
- Stock Information
- Founded
- TRC 1843
- ZBIO 2019
- Country
- TRC United States
- ZBIO United States
- Employees
- TRC N/A
- ZBIO N/A
- Industry
- TRC Real Estate
- ZBIO
- Sector
- TRC Finance
- ZBIO
- Exchange
- TRC Nasdaq
- ZBIO NYSE
- Market Cap
- TRC 463.5M
- ZBIO 389.2M
- IPO Year
- TRC N/A
- ZBIO 2024
- Fundamental
- Price
- TRC $16.55
- ZBIO $9.19
- Analyst Decision
- TRC
- ZBIO Strong Buy
- Analyst Count
- TRC 0
- ZBIO 7
- Target Price
- TRC N/A
- ZBIO $32.29
- AVG Volume (30 Days)
- TRC 104.4K
- ZBIO 202.0K
- Earning Date
- TRC 08-05-2025
- ZBIO 08-16-2025
- Dividend Yield
- TRC N/A
- ZBIO N/A
- EPS Growth
- TRC 298.28
- ZBIO N/A
- EPS
- TRC 0.08
- ZBIO N/A
- Revenue
- TRC $42,689,000.00
- ZBIO $15,000,000.00
- Revenue This Year
- TRC $0.64
- ZBIO $206.00
- Revenue Next Year
- TRC N/A
- ZBIO $41.92
- P/E Ratio
- TRC $207.56
- ZBIO N/A
- Revenue Growth
- TRC 7.04
- ZBIO N/A
- 52 Week Low
- TRC $14.71
- ZBIO $5.83
- 52 Week High
- TRC $19.82
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- TRC 53.63
- ZBIO N/A
- Support Level
- TRC $16.06
- ZBIO N/A
- Resistance Level
- TRC $16.55
- ZBIO N/A
- Average True Range (ATR)
- TRC 0.36
- ZBIO 0.00
- MACD
- TRC 0.04
- ZBIO 0.00
- Stochastic Oscillator
- TRC 77.12
- ZBIO 0.00
About TRC Tejon Ranch Co
Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely Real Estate - Commercial/Industrial, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.